These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1651686)
1. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881]. Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686 [TBL] [Abstract][Full Text] [Related]
2. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881]. Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707 [TBL] [Abstract][Full Text] [Related]
3. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension]. Toge T; Jinushi K; Sawamura A; Matsuki K Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687 [TBL] [Abstract][Full Text] [Related]
4. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881]. Saito T; Nakao I; Wakui A; Niitani H; Kurihara M; Konno T; Tsukagoshi S; Maeda H Gan To Kagaku Ryoho; 1991 Jul; 18(8):1319-23. PubMed ID: 1829883 [TBL] [Abstract][Full Text] [Related]
5. [Phase I clinical study of zinostatin stimalamer (YM 881) by intravenous injection]. Saito T; Nakao I; Wakui A; Kurihara M; Niitani H; Konno T; Tsukagoshi S; Maeda H Gan To Kagaku Ryoho; 1991 Jul; 18(8):1311-8. PubMed ID: 1829882 [TBL] [Abstract][Full Text] [Related]
6. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma]. Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684 [TBL] [Abstract][Full Text] [Related]
7. [Arterial infusion chemotherapy with SMANCS]. Nekohashi T; Maruno J; Sanjou A; Toda G Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025 [No Abstract] [Full Text] [Related]
8. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [TBL] [Abstract][Full Text] [Related]
9. A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma. Ishii H; Furuse J; Nagase M; Maru Y; Yoshino M; Hayashi T Jpn J Clin Oncol; 2003 Nov; 33(11):570-3. PubMed ID: 14711981 [TBL] [Abstract][Full Text] [Related]
10. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma]. Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683 [TBL] [Abstract][Full Text] [Related]
11. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma]. Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686 [TBL] [Abstract][Full Text] [Related]
12. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method]. Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522 [TBL] [Abstract][Full Text] [Related]
13. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium]. Maeda H Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma]. Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406 [TBL] [Abstract][Full Text] [Related]
15. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma]. Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma]. Inoue Y; Tomoda K; Oi H; Nakamura H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689 [TBL] [Abstract][Full Text] [Related]
18. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer]. Ikeda K; Saitoh S; Kumada H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682 [TBL] [Abstract][Full Text] [Related]
19. [An anaphylactic shock case after hepatic arterial infusion of zinostatin stimalamer suspension improved by anti-histaminics]. Fukuhara K; Suzuki M; Unno M; Rikiyama T; Sakamoto N; Takeuchi H; Uchiyama T; Yamaki T; Iwasashi H; Kodama H; Matsuno S Gan To Kagaku Ryoho; 1997 Jun; 24(8):1023-6. PubMed ID: 9212813 [TBL] [Abstract][Full Text] [Related]
20. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection]. Takano S; Kono S; Iwai S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]